102 related articles for article (PubMed ID: 1768503)
1. Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column.
Kojima S; Harada-Shiba M; Nomura S; Kimura G; Tsushima M; Kuramochi M; Yamamoto A; Omae T
ASAIO Trans; 1991; 37(4):644-8. PubMed ID: 1768503
[TBL] [Abstract][Full Text] [Related]
2. Effect of nafamostat mesilate on bradykinin generation and hemodynamics during LDL apheresis.
Kojima S; Shiba M; Kuramochi M; Yamamoto A
Artif Organs; 1995 Feb; 19(2):135-9. PubMed ID: 7763192
[TBL] [Abstract][Full Text] [Related]
3. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis.
Kojima S; Ogi M; Yoshitomi Y; Kuramochi M; Ikeda J; Naganawa M; Hatakeyama H
Int J Artif Organs; 1997 Mar; 20(3):178-83. PubMed ID: 9151155
[TBL] [Abstract][Full Text] [Related]
4. Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis.
Kojima S; Harada-Shiba M; Toyota Y; Kimura G; Tsushima M; Kuramochi M; Sakata T; Uchida K; Yamamoto A; Omae T
Int J Artif Organs; 1992 Mar; 15(3):185-90. PubMed ID: 1521904
[TBL] [Abstract][Full Text] [Related]
5. Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis.
Kojima S; Ogi M; Sugi T; Matsumoto Y; Yoshitomi Y; Kuramochi M
Ther Apher; 1997 Nov; 1(4):356-61. PubMed ID: 10225731
[TBL] [Abstract][Full Text] [Related]
6. Changes in plasma levels of cyclic nucleotides during low-density lipoprotein apheresis.
Kojima S; Yoshitomi Y; Sugi T; Matsumoto Y; Yano M; Kuramochi M
Ther Apher; 1998 Nov; 2(4):263-7. PubMed ID: 10227752
[TBL] [Abstract][Full Text] [Related]
7. Anaphylactoid reactions and bradykinin generation in patients treated with LDL-apheresis and an ACE inhibitor.
Koga N; Nagano T; Sato T; Kagasawa K
ASAIO J; 1993; 39(3):M288-91. PubMed ID: 8268545
[TBL] [Abstract][Full Text] [Related]
8. Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?
Kizaki Y; Ueki Y; Yoshida K; Yano M; Matsumoto K; Miyake S; Tominaga Y; Eguchi K; Yano K
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):341-9. PubMed ID: 10493215
[TBL] [Abstract][Full Text] [Related]
9. Contact activation in low-density lipoprotein apheresis systems.
Krieter DH; Steinke J; Kerkhoff M; Fink E; Lemke HD; Zingler C; Müller GA; Schuff-Werner P
Artif Organs; 2005 Jan; 29(1):47-52. PubMed ID: 15644083
[TBL] [Abstract][Full Text] [Related]
10. Selective continuous removal of low density lipoproteins by dextran sulfate cellulose column adsorption apheresis in the therapy of familial hypercholesterolemia.
Stefanutti C; Isacchi GC; Antonini R; Bucci A; Cardillo A; Di Nucci GD; Gozzer M; Malagnino F; Masci M; Mazzarella B
Beitr Infusionsther; 1988; 23():172-82. PubMed ID: 2484773
[No Abstract] [Full Text] [Related]
11. LDL apheresis by dextran sulfate cellulose (DSC) column in two patients with monogenic familial hypercholesterolemia (FH).
Aubert I; Bombail D; Erlich D; Goussault Y; Rouffy J; Bussel A
Prog Clin Biol Res; 1990; 337():205-7. PubMed ID: 1693782
[No Abstract] [Full Text] [Related]
12. Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns.
Koga N
Ther Apher; 1999 May; 3(2):155-60. PubMed ID: 10341391
[TBL] [Abstract][Full Text] [Related]
13. [Changes in serum lipids and lipoproteins in 3 cases of heterozygous familial hypercholesterolemia treated by LDL apheresis on dextran sulfate-cellulose columns].
Delplanque B; Emmerich J; Norol F; Jourdan D; Duedari N; Jacotot B
Ann Med Interne (Paris); 1988; 139 Suppl 1():80-2. PubMed ID: 2470282
[TBL] [Abstract][Full Text] [Related]
14. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis).
Mabuchi H; Michishita I; Takeda M; Fujita H; Koizumi J; Takeda R; Takada S; Oonishi M
Atherosclerosis; 1987 Nov; 68(1-2):19-25. PubMed ID: 2446636
[TBL] [Abstract][Full Text] [Related]
15. Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems.
Knisel W; Di Nicuolo A; Pfohl M; Müller H; Risler T; Eggstein M; Seifried E
J Intern Med; 1993 Nov; 234(5):479-87. PubMed ID: 8228792
[TBL] [Abstract][Full Text] [Related]
16. Plasma constituents other than low-density lipoprotein adsorbed by dextran-sulfate column.
Kojima S; Harada-Shiba M; Yamamoto A
Ther Apher; 1997 Nov; 1(4):309-13. PubMed ID: 10225721
[TBL] [Abstract][Full Text] [Related]
17. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
[TBL] [Abstract][Full Text] [Related]
18. Activation of coagulation by a LDL-apheresis device.
Giansante C; Bordin P; Fiotti N; Calabrese S; Petrucco A; Da Col PG; Fonda M; Cattin L
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):447-52. PubMed ID: 8839996
[TBL] [Abstract][Full Text] [Related]
19. LDL-apheresis by dextran sulfate cellulose adsorption columns: two methods.
Falco C; Scarpato N; Nappi G; Postiglione A; Gnasso A; Motti C; Montefusco S; Formisano S
Beitr Infusionsther; 1988; 23():191-4. PubMed ID: 2484777
[No Abstract] [Full Text] [Related]
20. Low-density lipoprotein apheresis and changes in plasma components.
Kojima S
Ther Apher; 2001 Aug; 5(4):232-8. PubMed ID: 11724506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
